PCSK9 Inhibitor, EGF-A
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
PCSK9 Inhibitor, EGF-A is an inhibitor of PCSK9. It corresponds to residues 293-334 of the EGF-A domain of the low-density lipoprotein (LDL) receptor. This compound prevents PCSK9-induced intracellular degradation of LDL receptors and can be utilized in the research of hypercholesterolemia and premature atherosclerosis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940049-100 1x 100 µL
CD31 / PECAM-1 (C31.3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
HA750162 100 µL
PI 3 Kinase p85 alpha Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 